Oxford Instruments PLC
01 July 2002
1 July 2002
Oxford Instruments sign collaboration agreement with Cambridge University
Oxford Instruments and Cambridge University have signed an agreement to create a
new laboratory that brings together two of the UK's leading superconducting
detector teams in a 20 year collaboration.
The groups will be located at the Cavendish Laboratory in Cambridge University
where their complementary areas of expertise will be combined in a new single
facility. The quality of the laboratory and calibre of the combined teams will
place the group in a strong position to create a new generation of analytical
techniques in the physical and biological sciences by developing advanced
systems and instruments based on analytical detectors.
The technology concerned includes the most sensitive sensors of light and other
radiation in the world and has potential applications ranging from the imaging
of DNA and other biological molecules to applications in astrophysics and
satellite-based detectors. For example, one of the detectors is so sensitive
that, if mounted in a satellite, it could detect the light and colour of a
cigarette being smoked in London.
Under the terms of the agreement Oxford Instruments' Cambridge-based Thin Films
team will combine their 15 years detector production experience with the
Cambridge team at the University. In addition, Oxford Instruments will license
its Intellectual Property to the laboratory and endow the University with a
donation of equipment to be used for fabricating and testing these devices which
will complement the infrastructure provided by a recent £3.5m government grant
to the University.
The Company will benefit from a royalty stream from any future commercial
developments arising from the exploitation of its intellectual property within
the new facility. In addition, the Company has an opportunity to make equipment
sales to the laboratory and to take up exploitation rights on key technology
developments relevant to its markets.
Andrew Mackintosh, Chief Executive of Oxford Instruments, said: "This
collaboration is an excellent example of the creative approach we are taking to
the exploitation of our intellectual property."
Enquiries contact:
Andrew Mackintosh, Oxford Instruments plc Tel: 01865 881437
Martin Lamaison, Oxford Instruments plc Tel: 01865 881437
Chris Barrie, Citigate Dewe Rogerson Tel: 020 7638 9571
Notes to editors
Oxford Instruments is a global leader in advanced instrumentation. It is
recognised as a world leader in several technologies, including the application
of superconductivity, the creation of low temperatures, the production and
detection of X-rays and in neurological measurements. The Company's products are
used around the world in healthcare, semiconductor processing, scientific
research, industrial chemical analysis and quality control. Its customers
include the world's major international companies as well as the leading
research institutes and hospitals.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.